Print page Resize text Change font-size Change font-size Change font-size High contrast


       

 

 

 

About ENCePP

Find out more about the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance.

 

Are you a company seeking to commission or collaborate in the conduct of a post-authorisation study (PAS)?

Find out more

Do you wish to register a study in the EU PAS Register?

Find out more

Are you considering applying for an ENCePP study seal?

Read a personal account of the ENCePP study approval process

Are you interested in the recommendations from the European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) on safety signals?

Review the list of signals discussed

 

 

 

Latest News
15 January 2020
EU PAS Register® technical upgrade with new functionalities

The European Union electronic Register of Post-Authorisation Studies (EU PAS Register®) is the publicly available register of non-interventional post-authorisation studies (PAS) maintained by the European Medicines Agency.

 

With the latest technical upgrade important functionalities have been added to meet our stakeholders’ business demands and to further increase transparency on non-interventional research for medicines authorised in the European Union.

 

The January 2020 upgrade includes a number of new functionalities based on the feed-back received from stakeholders:

With this upgrade further functionalities have been added to facilitate administrative tasks performed by the Agency.

 

The EU PAS Register continues to gain importance as is a unique source of information on the safety and effectiveness of authorised medicines. By the end of 2019 a total of 1,674 studies have been registered which represents an increase of about 20% over the previous year.

 

Related information:

»  EU PAS Register®

 

 

 

More news ...